# FDA Inspection 1210858 - Apellis Pharmaceuticals, Inc. - July 14, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/apellis-pharmaceuticals-inc/df07be3a-3241-4441-add0-8dac09ab5b36
Source feed: FDA_Inspections

> FDA Inspection 1210858 for Apellis Pharmaceuticals, Inc. on July 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210858
- Company Name: Apellis Pharmaceuticals, Inc.
- Inspection Date: 2023-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1134749 - 2020-11-13](https://www.globalkeysolutions.net/records/fda_inspections/apellis-pharmaceuticals-inc/e4ecdf0a-d8b8-495e-93b8-b8025f36e1da)

Company: https://www.globalkeysolutions.net/companies/apellis-pharmaceuticals-inc/638e1bdb-677f-4212-a838-bc867c5f0e53

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c